Literature DB >> 9486387

Subclass distribution of IgA antibodies in saliva and serum after immunization with Haemophilus influenzae type b conjugate vaccines.

M Kauppi-Korkeila1, L Saarinen, J Eskola, H Käyhty.   

Abstract

IgA subclass distribution of antibodies against capsular polysaccharide (PS) of Haemophilus influenzae type b (Hib) was studied in saliva and serum samples of children vaccinated with two (n = 58) or three doses (n = 53) of Hib vaccine. One month after the second dose of Hib conjugate vaccine, at 7 months old, 40% of the children had IgA1 and 41% had IgA2 anti-Hib PS antibodies in saliva. One month after the third dose, at 15-25 months old, IgA1 was the predominating subclass; 72% of the children had IgA1, 26% had IgA2 anti-Hib PS in saliva. The mean concentration of IgA1 anti-Hib PS, expressed as optical density (OD) values, was significantly higher after three doses (OD 80.7) than after two doses (OD 18.9). The mean concentration of IgA2 did not change significantly after the third dose (OD 23.8 after two doses, OD 18.1 after three doses). In serum, IgA1 anti-Hib PS predominated both after two (17% had IgA1, none had IgA2) and three doses (72% had IgA1, 4% had IgA2) of Hib vaccine. In conclusion, both IgA1 and IgA2 anti-Hib PS were found in saliva of immunized children after two doses of Hib conjugate vaccine, whereas the third vaccine dose induced a shift towards IgA1 anti-Hib PS dominance in saliva.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9486387      PMCID: PMC1904911          DOI: 10.1046/j.1365-2249.1998.00501.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

1.  Detection of Haemophilus influenzae type B antigen in cerebrospinal fluid after immunization.

Authors:  T Darville; R F Jacobs; R A Lucas; B Caldwell
Journal:  Pediatr Infect Dis J       Date:  1992-03       Impact factor: 2.129

2.  Heavy-chain isotype patterns of human antibody-secreting cells induced by Haemophilus influenzae type b conjugate vaccines in relation to age and preimmunity.

Authors:  T Barington; L Juul; A Gyhrs; C Heilmann
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

3.  Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines.

Authors:  J C Mohle-Boetani; G Ajello; E Breneman; K A Deaver; C Harvey; B D Plikaytis; M M Farley; D S Stephens; J D Wenger
Journal:  Pediatr Infect Dis J       Date:  1993-07       Impact factor: 2.129

4.  Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian children.

Authors:  A K Takala; M Santosham; J Almeido-Hill; M Wolff; W Newcomer; R Reid; H Käyhty; E Esko; P H Mäkelä
Journal:  Pediatr Infect Dis J       Date:  1993-07       Impact factor: 2.129

5.  A comparison of salivary immunoglobulin A (IgA) and IgA subclass concentrations in predentate and dentate children and adults.

Authors:  A R Tappuni; S J Challacombe
Journal:  Oral Microbiol Immunol       Date:  1994-06

6.  Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine.

Authors:  A K Takala; J Eskola; M Leinonen; H Käyhty; A Nissinen; E Pekkanen; P H Mäkelä
Journal:  J Infect Dis       Date:  1991-11       Impact factor: 5.226

7.  Mucosal antibodies to Haemophilus influenzae type b capsular polysaccharide.

Authors:  J R Gilsdorf; W M McDonnell
Journal:  Pediatr Res       Date:  1991-05       Impact factor: 3.756

Review 8.  Molecular heterogeneity of human IgA antibodies during an immune response.

Authors:  M W Russell; C Lue; A W van den Wall Bake; Z Moldoveanu; J Mestecky
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

9.  Anti-capsular polysaccharide antibodies reduce nasopharyngeal colonization by Haemophilus influenzae type b in infant rats.

Authors:  M Kauppi; L Saarinen; H Käyhty
Journal:  J Infect Dis       Date:  1993-02       Impact factor: 5.226

10.  Parenteral influenza vaccination induces a rapid systemic and local immune response.

Authors:  K A Brokstad; R J Cox; J Olofsson; R Jonsson; L R Haaheim
Journal:  J Infect Dis       Date:  1995-01       Impact factor: 5.226

View more
  4 in total

Review 1.  Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria.

Authors:  Q Zhang; A Finn
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

2.  Subclass distribution of natural salivary IgA antibodies against pneumococcal capsular polysaccharide of type 14 and pneumococcal surface adhesin A (PsaA) in children.

Authors:  B Simell; T Kilpi; H Käyhty
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

3.  Enhancement of serum and mucosal immune responses to a Haemophilus influenzae Type B vaccine by intranasal delivery.

Authors:  Stefan Fernandez; Emily D Cisney; Robert G Ulrich
Journal:  Clin Vaccine Immunol       Date:  2013-08-28

4.  Salivary antibodies induced by the seven-valent PncOMPC conjugate vaccine in the Finnish Otitis Media Vaccine Trial.

Authors:  Anu Nurkka; Mika Lahdenkari; Arto A I Palmu; Helena Käyhty
Journal:  BMC Infect Dis       Date:  2005-05-27       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.